Rising prevalence of birth defects worldwide has produced a significant rise in infant mortality cases.
Rising prevalence of birth defects worldwide has produced a significant rise in infant mortality cases. In fact, as per CDC statistics, the infant mortality rate in the United States during 2018 was recorded to be around 5.7 deaths per 1000 live births. Moreover, over 3 lakh newborns die annually worldwide due to birth defects. These daunting statistics have put forth a need for potential treatment and testing solutions which could, up to some extent, decrease the chances of birth defects, eventually paving way for the development and use of prenatal and newborn genetic testing procedure.
It has been estimated that the global prenatal and newborn genetic testing market is set to record an annual valuation of USD 7 billion from 2018 to 2024, given the prominence of below mentioned trends:
Revolutionary technological breakthroughs in prenatal and newborn genetic testing procedures
Technological advancements have been the center point of product development today in almost all industries. Infant genetic testing business space is no exception to this. Introduction of prenatal testing has led to a considerable amount of increase in the adoption rate of new testing technologies like non-invasive prenatal testing for detection of sub chromosomal abnormalities, aneuploidy, and single-gene disorders in the North American region.
Increasing consanguineous relations across emerging economies
An increasing count of consanguineous relations in the emerging economies of the Middle East and Asian regions is expected to foster the growth opportunities for prenatal and newborn genetic testing market. These relations are generally responsible for birth of infants with defects and chromosomal anomalies. Consequently, a prolific rise in cases of live births detected with birth defects is also likely to directly influence the growth curve of prenatal and newborn genetic testing business space.
Rising prominence of screening technology
The screening technology segment across the global prenatal and newborn genetic testing market had in 2017 acquired a lion’s share in the overall industry. This can be ascribed to the rising number of screening procedures for pregnant women while delivery. Besides, an upsurge in awareness amongst the families regarding genetic birth defects, aligned with early detection of genetic disorder is touted to augment the industry outlook in the upcoming years.
To access sample pages of this report titled, “Prenatal and New-born Genetic Testing Market Size By Technology (Screening {Chorionic Villus Sampling, Maternal Serum Screening, Amniocentesis, Non-invasive prenatal testing}, Diagnostic {mmPCR, Spectrophotometer, FISH, Assays), By Disease (Downs Syndrome, Phenylketonuria, Cystic Fibrosis, Sickle Cell Anaemia), By End-use (Hospitals, Maternity & Specialty Clinics, Diagnostic Centres), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2018 – 2024” in detail along with the table of contents, please click on the link below:
https://www.gminsights.com/request-sample/detail/1906
Proliferating need for newborn and prenatal testing for Downs Syndrome
According to CDC statistics, about 6,000 babies are born with Downs Syndrome in the United States. This count has accentuated the demand for proper prenatal and newborn testing which is in turn adding to the escalating dynamics of the global prenatal and newborn genetic testing market. What has been acting as a leading cause for this anomaly is the rise in incidences of women getting married at later stages of their lives.
Shifting inclination towards prenatal and newborn genetic testing in hospital settings
Parents and families have been laying immense focus on undergoing prenatal and newborn genetic testing procedures at authentic hospitals which are funded by the government, as they offer the facilities well-required for newborn screening. That said, a subtle increase in number of screening programs in the healthcare setting offers considerable scope for prenatal and newborn genetic testing market growth.
Augmenting newborn screening rates across the United States
Given that the rate of infant mortality and birth defects is highest in the United States, it would be essential to note that the country is likely to emerge as a lucrative growth ground for overall prenatal and newborn genetic testing market. Thanks to the ongoing technological developments and introduction of favorable reimbursement policies. Experts have suggested that the country boasts of 99% newborn screening rate to date, which is deemed to be responsible for the prenatal and newborn genetic testing market growth in the nation.
About Global Market Insights, Inc.
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.
Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Website: https://www.gminsights.com